Peritoneal Dialysis International最新文献

{"title":"Corrigendum to \"Utilization of CMS pre-ESRD Kidney Disease Education services and its associations with the home dialysis therapies\".","authors":"","doi":"10.1177/08968608261451420","DOIUrl":"10.1177/08968608261451420","url":null,"abstract":"","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"600"},"PeriodicalIF":1.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147982733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Nutrition management in peritoneal dialysis: Regaining our sense of control.","authors":"Karrin Davidson, Nicole Scholes-Robertson","doi":"10.1177/08968608261485762","DOIUrl":"10.1177/08968608261485762","url":null,"abstract":"","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"417-418"},"PeriodicalIF":1.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148906648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Predictive value of BRI for clinical outcomes in peritoneal dialysis patients remains to be determined.","authors":"Fan Zhang","doi":"10.1177/08968608261469975","DOIUrl":"10.1177/08968608261469975","url":null,"abstract":"","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"596"},"PeriodicalIF":1.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148471896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pilot randomised controlled trial evaluating feasibility, safety and adherence to psyllium husk in peritoneal dialysis: The FIBRE-PD trial.","authors":"Chloe Howard, David W Johnson, Carmel M Hawley, Kylie Pegg, Hannah Mayr, Diana Leary, Rachael Hale, Andrea K Viecelli, Janette Hamilton, Vicki Thomas, Irish Dela-Pena, Yeoungjee Cho","doi":"10.1177/08968608261429654","DOIUrl":"10.1177/08968608261429654","url":null,"abstract":"<p><p>BackgroundPatients receiving peritoneal dialysis (PD) often report problems with constipation. Constipation in PD is associated with increased risks of mechanical and infectious complications, such as poor drainage and fluid removal, catheter migration and peritonitis. A natural fibre supplement, psyllium husk, has been identified as a potential alternative therapy to minimise the risk of constipation for patients receiving PD.MethodsFIBRE-PD is a prospective parallel-arm open-label feasibility study in which patients on PD were 1:1 randomly assigned to receive either psyllium husk (intervention group) or continue routine Movicol^® (control group) for four weeks (28 days). The primary outcome was feasibility, defined as successful recruitment of 60 patients, representing 70% of eligible PD patients. Secondary outcomes included adherence, retention, safety, bowel frequency and patient-reported outcomes (e.g., gastrointestinal symptom burden, quality of life).ResultsOverall, 96 patients were screened for eligibility. Sixty-six (69%) were deemed not eligible, mainly due to non-adherence to prescribed regular Movicol (<i>n = </i>41, 62%). Among 30 eligible patients, 20 patients (67% of eligible population) were successfully recruited into the study. The intervention group demonstrated high retention (77%), adherence rates (78%) and significant improvement in gastrointestinal symptoms and quality of life compared to patients in the control group. No adverse outcomes were reported.ConclusionThe FIBRE-PD did not meet its original recruitment target due to an unexpectedly high number of ineligible patients. The recruited proportion almost reached the pre-specified target of 70% of eligible patients, and participants in the intervention group demonstrated high retention and adherence rates with observed benefits in gastrointestinal symptom burden and quality of life.</p>","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"510-517"},"PeriodicalIF":1.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148034142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Nourishing equity and outcomes: The first international recommendations for peritoneal dialysis nutrition.","authors":"Lina Johansson, Nicola Ruddock","doi":"10.1177/08968608261478168","DOIUrl":"10.1177/08968608261478168","url":null,"abstract":"","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"419-421"},"PeriodicalIF":1.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148796590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Differences in dietary intake assessed by dietary recall and that estimated by protein nitrogen appearance rate.","authors":"Haalah Shaaker, Andrew Davenport","doi":"10.1177/08968608261420122","DOIUrl":"10.1177/08968608261420122","url":null,"abstract":"<p><p>Peritoneal dialysis (PD) patients are at risk of muscle wasting and clinical guidelines recommend assessing dietary intake, by calculating protein equivalent of nitrogen appearance (PNA) to assure adequate intake. As the PNA equations were developed some time ago based on continuous ambulatory PD (CAPD) treatments, we re-evaluated them by comparing dietary recall protein intake. Dietary histories were obtained from 42 PD patients, mean age 62.2 ± 15.8 years, 58.1% male, 41.9% white, 39.5% treated with CAPD, median dialysis vintage 13.2 (3.1-23.3) months when attending for routine outpatient peritoneal membrane testing. Dietary protein intake (DPI), median 50.8 (37.5-71.5) g/day was determined with the Nutrics software program^®, and using PNA equations, DPI varied from 32.6 (31-34.3) to 68.8 (58.7-86.3) g/day. Bland Altman bias ranged from -22.8 ± 23.4 to +12.0 ± 24.6 g/day, with the older equations tending to underestimate and the more recent equations overestimating dietary recall DPI. There was systematic bias with the older equations, particularly as DPI increased. Although there was a wide variation, the two equations exhibiting least variation with dietary DPI were: PNA=15.1 + (0.195 × 24-h combined urinary and peritoneal urea mmol) + (24-h combined urinary and peritoneal protein loss), and PNA = 20.1 + (0.209 × 24-h combined urinary and peritoneal urea mmol), with a mean bias of +6.3 and +7.8 g/day compared to dietary DPI, and negative nitrogen balance of -1.7 and 2.6 g/day, respectively. Our study would suggest that the most used PNA equations may overestimate DPI in many patients and potentially result in unrecognised protein malnutrition.</p>","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"588-592"},"PeriodicalIF":1.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146132715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Advances in sorbent peritoneal dialysis technologies: A narrative review.","authors":"Susan Bríd McGrath, Pauline Kosalka, Marjorie W Foo, Htay Htay, Edwina A Brown, Karin Gf Gerritsen, Olof Heimbürger, Arsh K Jain","doi":"10.1177/08968608251371951","DOIUrl":"10.1177/08968608251371951","url":null,"abstract":"<p><p>Sorbent peritoneal dialysis (SPD) removes a tidal volume of spent dialysate, passing it through sorbent layers before infusing replacement electrolytes and dextrose to regenerate dialysate. We examine the five devices using SPD in published literature, reviewing their design, dialysis clearance, and ultrafiltration (UF) capacity-Automated Wearable Artificial Kidney (AWAK), now called Viva Kompact since 2024, Carry Life System PD/Carry Life UF, Wearable Artificial Kidney (WEAKID), Vicenza Wearable Artificial Kidney (ViWAK), and Renart-PD. Carry Life devices and Viva Kompact have reported on human trials, WEAKID and Renart-PD on animal studies, while ViWAK has published in vitro data. All devices have published data on dialysis clearance capabilities. WEAKID and Carry Life PD achieved a high dialysate:plasma concentration gradient for small solutes. Viva Kompact and Renart-PD reported stable or lower serum concentrations of urea, creatinine, phosphate, and β2-microglogulin following treatments. ViWAK demonstrated removal of creatinine, B2 microglobulin, and angiogenin to <10% of pre-treatment levels. UF capacity remains unknown for many devices. In human trials, Carry Life UF has achieved 863 mL UF in a 5-h treatment with the addition of 20 g/h of glucose to 1.5% dextrose dialysate. Viva Kompact has demonstrated 877 mL UF in a 9-h treatment using 1.5% dextrose dialysate in an animal model, comparable to 10-h APD, with the addition of 6.6 g/h glucose. Both devices have demonstrated improved UF per gram of glucose used. The expected use of these devices varies greatly, from an adjunct to currently available treatments to a complete replacement for current modalities. Large-scale, human studies are needed to determine their role in the future of PD delivery.</p>","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"499-509"},"PeriodicalIF":1.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145086665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reading beyond the abstract and conclusion: Embracing diagnostic technology-continuous glucose monitoring and positron emission tomography-while safeguarding individuals receiving peritoneal dialysis.","authors":"James A Sloand","doi":"10.1177/08968608261429726","DOIUrl":"10.1177/08968608261429726","url":null,"abstract":"","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"424-427"},"PeriodicalIF":1.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147434581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Modified creatinine index as a noninvasive tool for the monitoring of muscle mass in peritoneal dialysis.","authors":"Miłosz Miedziaszczyk, Jack Kit-Chung Ng, Winston Wing-Shing Fung, Gordon Chun-Kau Chan, Kai-Ming Chow, Cheuk-Chun Szeto","doi":"10.1177/08968608261456380","DOIUrl":"10.1177/08968608261456380","url":null,"abstract":"<p><p>BackgroundThe dialysis process negatively affects skeletal muscle mass and function by disrupting metabolic and nutritional balance. A previous study showed that single time-point measurement of modified creatinine index (MCrI) was a simple and reliable marker of skeletal muscle mass. The present study aims to evaluate whether serial monitoring of MCrI can detect changes in skeletal muscle mass and predict treatment outcomes in patients undergoing peritoneal dialysis (PD).MethodsWe studied 351 new adult PD patients. MCrI values were calculated by a validated formula at baseline and then every 6 months for 2 years. At the same time, lean tissue mass (LTM) was assessed by bioimpedance spectroscopy and fat-free edema-free body mass (FEBM) by traditional creatinine kinetic methods. The patients were followed for 59.2 ± 32.7 months for survival and hospitalization.ResultsWhen the percentage change in LTM (Δ%LTM) was taken as the reference, modified Bland-and-Altman analysis showed that the bias of percentage change of MCrI (Δ%MCrI) was +4.9%, with the limits of agreement -26.6 to +36.4%. When the percentage change in FEBM (Δ%FEBM) was taken as the reference, the bias of Δ%MCrI was -7.0%, with limits of agreement -35.4 to 21.3%. There was no significant association between Δ%MCrI and patient survival, hospital admission, or peritonitis rate.ConclusionsThe change in MCrI does not reliably represent the change in muscle mass in PD patients. Further research is needed to identify other noninvasive method for evaluating muscle mass in the PD population.</p>","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"578-587"},"PeriodicalIF":1.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148101811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Joint International Society of Renal Nutrition and Metabolism (ISRNM) and International Society for Peritoneal Dialysis (ISPD) practice recommendation on nutrition management in peritoneal dialysis.","authors":"Angela Yee-Moon Wang, Carla Maria Avesani, Deepa Kariyawasam, Kelly Lambert, Christine Nash, Fabiana Nerbass, Alice Sabatino, Ammar Alobaidi, Sharon Devi Naraine, Maria Chan, Josephine Sf Chow, Jie Dong, Zarina Ebrahim, Ana E Figueiredo, Scott E Liebman, Connie Rhee, Maryanne Zilli Canedo Silva, David W Johnson","doi":"10.1177/08968608261458140","DOIUrl":"10.1177/08968608261458140","url":null,"abstract":"<p><p>Nutrition is a key management issue in individuals receiving peritoneal dialysis (PD) and those who develop complications during PD. However, globally, there is no unified practice consensus to guide nephrologists, dietitians and other allied health professionals in managing various nutrition issues for individuals receiving PD. The International Society of Renal Nutrition and Metabolism (ISRNM) and International Society for Peritoneal Dialysis (ISPD) joined forces to develop an inaugural practice recommendation on nutrition management in individuals receiving PD. The practice recommendation was developed by a globally representative group of nephrologists, dietitians and dialysis nurses. It aims to provide comprehensive clinical guidance on nutrition management to nephrologists, non-nephrologist physicians, dietitians, nurses and multidisciplinary care teams for implementation in individuals receiving PD to optimise their nutrition status, prevent and manage protein-energy wasting, promote a healthy dietary pattern, improve patient-centred outcomes, enabling them to live well on PD. A multidisciplinary education approach is promoted to improve patients' health, nutrition and food literacy in order for them to adopt a healthy dietary pattern and promote more individuals' engagement in self-managing their diets and nutrition. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework was used to evaluate the quality of evidence and grade practice recommendations. Practice points are developed based on expert consensus of health professionals. The practice recommendation covers five key themed topics: nutrition screening and assessment and monitoring of nutrition status, dietary recommendations for individuals receiving PD, nutrition interventions for individuals who develop complications while receiving PD, nutrition supplementation and nutrition education.</p>","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"431-498"},"PeriodicalIF":1.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149040253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}